(DURHAM, N.C.)Inspire Pharmaceuticals Inc. said Tuesday it is expanding a late-stage study of its cystic fibrosis drug candidate, doubling the time period and boosting patient enrollment.READ MORE
(NEW YORK)More than 50 companies in the health care sector were added to the Russell 2000 in this year's reconstitution of the small stock index, while 30 companies in the sector were re...READ MORE
(NEW YORK)Shares of Inspire Pharmaceuticals Inc. surged Friday after the drug developer said its developing cystic fibrosis treatment improved patients' lung function in a late-stage stu...READ MORE
Among the stock activity stories for Friday, June 6, from AP Financial News: NEW YORK (AP)--Shares of poultry producer Sanderson Farms Inc. dropped Friday after a Stephens Inc. ana...READ MORE
(NEW YORK)Despite its strong first-quarter results, shares of Chinese solar power company Trina Solar Ltd. skidded in premarket trading Friday. Dow Jones industrial average futures also were...READ MORE
(DURHAM, N.C.)Drug maker Inspire Pharmaceuticals Inc. said Friday that a late-stage trial of its drug to treat cystic fibrosis, a disease that produces thick, sticky mucus in the lungs, met its ...READ MORE